Rome, January 7 – Vaccinations and tests to detect coronavirus pushed the accounts of the first quarter of fiscal year 2021/2022 (expired on November 20, 2021) of the Walgreens Boots Alliance, which closed with results above estimates, both much that team has increased Directive for the whole financial year. This was reported in a press release by the same multinational group, one of the leading players in the world in the fields of pharmaceutical distribution, integrated healthcare and retail. The first quarter ended with earnings per share (eps) from continuing operations of $ 4.13, compared to a loss of $ 0.45 in the same period a year ago.
LARGE’eps custom of continuing operations is $ 1.68, marking an increase of 53.1% at fixed exchange rates. Ongoing operating income was $ 3.6 billion, compared with a loss of $ 391 million in the first quarter of last year. Ongoing operating income increased 7.8% to $ 33.9 billion (+ 7.6% at constant exchange rates). Operating income for the period, also from continuing operations, was $ 1.3 billion, compared with a loss of $ 535 million a year ago. Adjusted operating profit was $ 1.8 billion (+ 48.5% at constant exchange rates).
As the press release states, “The results exceeded expectations in various business sectors, due to vaccinations and Covid-19 tests, comparable retail sales in the United States increased by 10.6% and comparable retail sales in Boots Uk increased by 16.3%..
In the first quarter of the year, Walgreens performed 15.6 million vaccinations and 6.5 million tests. For the whole year, the forecast foreps customizationd has been elevated and is ogrowth of up to 5% is expected. The estimate continues to predict a negative impact of 4 percentage points linked to the impact of planned investments in healthcare.
“The results of the first quarter exceeded expectations with a very encouraging performance in all our business areas. I’m very excited about the progress being made by the Walgreens Health department. “ commented Pink BrewerWba CEO. “We completed the acquisition of a majority stake in VillageMD and Shields during the quarter and are now launching VillageMD Primary Care Co-locations and Walgreens Health Corners. The promising start to this financial year strengthens our confidence for the future, which is why we have increased our guidance throughout the year and increased investment for the benefit of our people.. I look forward – concluded Brewer – we are in a good position for sustainable and long-term value creation“.